Neurotrack

About:

Neurotrack develops digital cognitive health screening solutions to reduce the risk of Alzheimer's and related dementias.

Website: https://neurotrack.com/

Twitter/X: neurotrack

Top Investors: Khosla Ventures, Founders Fund, National Institutes of Health, Rethink Impact, Rock Health Capital

Description:

Neurotrack is a digital health company on a mission to transform the diagnosis and management of Alzheimer's and other dementias. The company develops turnkey tools for providers that can be easily delivered at scale to facilitate early detection of cognitive impairment and ongoing monitoring of cognitive function. Neurotrack's patient-guided, clinically-validated cognitive assessments work in the clinic or at home to fit any workflow. Neurotrack has published 27 peer-reviewed papers, holds 11 patents on its proprietary technology, and is registered as an FDA Class II medical device. For more information visit neurotrack.com. The company was founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola and is based in Redwood City, California.